Differential control of uterine artery endothelial monolayer integrity by TNF and VEGF is achieved through multiple mechanisms operating inside and outside the cell – Relevance to preeclampsia
Uterine artery endothelium undergoes a form of functional adaptation during pregnancy because of an increase in Cx43 communication, resulting in increased Ca2+/IP3 exchange and more synchronous and sustained vasodilator production. We have shown previously that acute exposure to growth factors and T...
Gespeichert in:
Veröffentlicht in: | Molecular and cellular endocrinology 2021-08, Vol.534, p.111368-111368, Article 111368 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 111368 |
---|---|
container_issue | |
container_start_page | 111368 |
container_title | Molecular and cellular endocrinology |
container_volume | 534 |
creator | Ampey, Amanda C. Dahn, Rachel L. Grummer, Mary A. Bird, Ian M. |
description | Uterine artery endothelium undergoes a form of functional adaptation during pregnancy because of an increase in Cx43 communication, resulting in increased Ca2+/IP3 exchange and more synchronous and sustained vasodilator production. We have shown previously that acute exposure to growth factors and TNF can block this adaptation through ERK and/or Src-mediated Cx43 phosphorylation. In preeclampsia such adapted function is already missing, but while elevated TNF is associated with this condition, particularly after 28 weeks (late PE), elevated circulating VEGF165 is not. Given PE is a long term condition emerging in the second half of pregnancy, and is often associated with added edema, we now compare the chronic effects of these two factors on the cell monolayer in order to establish if the breakdown of junctional adherens and tight junctional assemblies in which Cx43 resides could also explain loss of vasodilatory function. We report that while TNF can degrade monolayer integrity even in the 0.1–1 ng/ml physiologic range, VEGF up to 10 ng/ml does not. In addition, the progressive action of TNF is mediated through Src and ERK signaling to promote internalization and destruction of VE-Cadherin (VE-Cad) and ZO-1, as well as the expression and secretion of a variety of proteases. At least one protein degraded from the extracellular space is VE-Cad, resulting in release of a shed VE-Cad protein product, and consistent with monolayer breakdown being sensitive to both Src and MEK/ERK kinase inhibitors and the general protease inhibitor GM6001. We conclude that the greater association of TNF with ‘late’ PE is as much due to its longer term destabilizing effects on junctional assemblies as it is to acute closure of Cx43 channels themselves. New therapies aimed at stabilizing these junctional assemblies may help treat this hypertensive condition.
•TNF but not VEGF damages junctional assemblies at physiologic levels in uterine artery endothelial cells.•TNF acts through multiple mechanisms inside and outside the cell to cause this damage.•Our data supports the argument cytokines are more damaging than growth factors in loss of vasodilation in the preeclampsia. |
doi_str_mv | 10.1016/j.mce.2021.111368 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8344923</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0303720721002124</els_id><sourcerecordid>2544158229</sourcerecordid><originalsourceid>FETCH-LOGICAL-c451t-7e8a97e7b89c433b096e490310c4cffa3acb807842402f2f819c30cdf77370493</originalsourceid><addsrcrecordid>eNp9kc2KFDEUhQtRnHb0AdxIlm66zV91UgiCjNOjMCjI6DakUre60qSSMkk19M538I18FJ_E9PQ46MZVLsm537m5p6qeE7wimKxf7VajgRXFlKwIIWwtH1QLIgVdSlyLh9UCM8yWgmJxVj1JaYcxFjWVj6szxknNmJCL6uc72_cQwWerHTLB5xgcCj2aM0TrAelYigMC34U8gDuqxuCD0weIyPoM22jzAbUHdPNxg7Tv0NfLqw2yCWkzWNhDh_IQw7wd0Di7bCcHaAQzaG_TmFCYIOps_bawku3glhDmfFsXQ2TAOfTr-w_0GRzstTflOqApAhinxylZ_bR61GuX4NndeV592VzeXLxfXn-6-nDx9nppeE3yUoDUjQDRysZwxlrcrIE3mBFsuOl7zbRpJRaSU45pT3tJGsOw6XohmMC8YefVmxN3mtsROlN2FrVTU7SjjgcVtFX_vng7qG3YK8k4bygrgJd3gBi-zZCyGm06_k97CHNStOYlF0np0YucpCaGlCL09zYEq2P2aqdK9uqYvTplX3pe_D3ffcefsIvg9UkAZUt7C1ElY6FstLMRTFZdsP_B_wacvsV7</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2544158229</pqid></control><display><type>article</type><title>Differential control of uterine artery endothelial monolayer integrity by TNF and VEGF is achieved through multiple mechanisms operating inside and outside the cell – Relevance to preeclampsia</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Ampey, Amanda C. ; Dahn, Rachel L. ; Grummer, Mary A. ; Bird, Ian M.</creator><creatorcontrib>Ampey, Amanda C. ; Dahn, Rachel L. ; Grummer, Mary A. ; Bird, Ian M.</creatorcontrib><description>Uterine artery endothelium undergoes a form of functional adaptation during pregnancy because of an increase in Cx43 communication, resulting in increased Ca2+/IP3 exchange and more synchronous and sustained vasodilator production. We have shown previously that acute exposure to growth factors and TNF can block this adaptation through ERK and/or Src-mediated Cx43 phosphorylation. In preeclampsia such adapted function is already missing, but while elevated TNF is associated with this condition, particularly after 28 weeks (late PE), elevated circulating VEGF165 is not. Given PE is a long term condition emerging in the second half of pregnancy, and is often associated with added edema, we now compare the chronic effects of these two factors on the cell monolayer in order to establish if the breakdown of junctional adherens and tight junctional assemblies in which Cx43 resides could also explain loss of vasodilatory function. We report that while TNF can degrade monolayer integrity even in the 0.1–1 ng/ml physiologic range, VEGF up to 10 ng/ml does not. In addition, the progressive action of TNF is mediated through Src and ERK signaling to promote internalization and destruction of VE-Cadherin (VE-Cad) and ZO-1, as well as the expression and secretion of a variety of proteases. At least one protein degraded from the extracellular space is VE-Cad, resulting in release of a shed VE-Cad protein product, and consistent with monolayer breakdown being sensitive to both Src and MEK/ERK kinase inhibitors and the general protease inhibitor GM6001. We conclude that the greater association of TNF with ‘late’ PE is as much due to its longer term destabilizing effects on junctional assemblies as it is to acute closure of Cx43 channels themselves. New therapies aimed at stabilizing these junctional assemblies may help treat this hypertensive condition.
•TNF but not VEGF damages junctional assemblies at physiologic levels in uterine artery endothelial cells.•TNF acts through multiple mechanisms inside and outside the cell to cause this damage.•Our data supports the argument cytokines are more damaging than growth factors in loss of vasodilation in the preeclampsia.</description><identifier>ISSN: 0303-7207</identifier><identifier>EISSN: 1872-8057</identifier><identifier>DOI: 10.1016/j.mce.2021.111368</identifier><identifier>PMID: 34153378</identifier><language>eng</language><publisher>Ireland: Elsevier B.V</publisher><subject>Antigens, CD - metabolism ; Cadherins - metabolism ; Cell Culture Techniques ; Cells, Cultured ; Connexin 43 - metabolism ; Culture Media - chemistry ; Edema ; Endothelial Cells - cytology ; Endothelial Cells - drug effects ; Endothelial Cells - metabolism ; Endothelial dysfunction ; Female ; Gene Expression Regulation ; Humans ; Hypertension ; Junctional proteins ; MAP Kinase Signaling System - drug effects ; Models, Biological ; Phosphorylation - drug effects ; Pre-Eclampsia - metabolism ; Pregnancy ; src-Family Kinases - metabolism ; TNF-Alpha ; Tumor Necrosis Factor-alpha - metabolism ; Tumor Necrosis Factor-alpha - pharmacology ; Uterine Artery - cytology ; Uterine Artery - drug effects ; Uterine Artery - metabolism ; Vascular Endothelial Growth Factor A - metabolism ; Vascular Endothelial Growth Factor A - pharmacology ; Zonula Occludens-1 Protein - metabolism</subject><ispartof>Molecular and cellular endocrinology, 2021-08, Vol.534, p.111368-111368, Article 111368</ispartof><rights>2021</rights><rights>Published by Elsevier B.V.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c451t-7e8a97e7b89c433b096e490310c4cffa3acb807842402f2f819c30cdf77370493</citedby><cites>FETCH-LOGICAL-c451t-7e8a97e7b89c433b096e490310c4cffa3acb807842402f2f819c30cdf77370493</cites><orcidid>0000-0002-0396-058X ; 0000-0003-2444-5816</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0303720721002124$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,776,780,881,3536,27903,27904,65309</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34153378$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ampey, Amanda C.</creatorcontrib><creatorcontrib>Dahn, Rachel L.</creatorcontrib><creatorcontrib>Grummer, Mary A.</creatorcontrib><creatorcontrib>Bird, Ian M.</creatorcontrib><title>Differential control of uterine artery endothelial monolayer integrity by TNF and VEGF is achieved through multiple mechanisms operating inside and outside the cell – Relevance to preeclampsia</title><title>Molecular and cellular endocrinology</title><addtitle>Mol Cell Endocrinol</addtitle><description>Uterine artery endothelium undergoes a form of functional adaptation during pregnancy because of an increase in Cx43 communication, resulting in increased Ca2+/IP3 exchange and more synchronous and sustained vasodilator production. We have shown previously that acute exposure to growth factors and TNF can block this adaptation through ERK and/or Src-mediated Cx43 phosphorylation. In preeclampsia such adapted function is already missing, but while elevated TNF is associated with this condition, particularly after 28 weeks (late PE), elevated circulating VEGF165 is not. Given PE is a long term condition emerging in the second half of pregnancy, and is often associated with added edema, we now compare the chronic effects of these two factors on the cell monolayer in order to establish if the breakdown of junctional adherens and tight junctional assemblies in which Cx43 resides could also explain loss of vasodilatory function. We report that while TNF can degrade monolayer integrity even in the 0.1–1 ng/ml physiologic range, VEGF up to 10 ng/ml does not. In addition, the progressive action of TNF is mediated through Src and ERK signaling to promote internalization and destruction of VE-Cadherin (VE-Cad) and ZO-1, as well as the expression and secretion of a variety of proteases. At least one protein degraded from the extracellular space is VE-Cad, resulting in release of a shed VE-Cad protein product, and consistent with monolayer breakdown being sensitive to both Src and MEK/ERK kinase inhibitors and the general protease inhibitor GM6001. We conclude that the greater association of TNF with ‘late’ PE is as much due to its longer term destabilizing effects on junctional assemblies as it is to acute closure of Cx43 channels themselves. New therapies aimed at stabilizing these junctional assemblies may help treat this hypertensive condition.
•TNF but not VEGF damages junctional assemblies at physiologic levels in uterine artery endothelial cells.•TNF acts through multiple mechanisms inside and outside the cell to cause this damage.•Our data supports the argument cytokines are more damaging than growth factors in loss of vasodilation in the preeclampsia.</description><subject>Antigens, CD - metabolism</subject><subject>Cadherins - metabolism</subject><subject>Cell Culture Techniques</subject><subject>Cells, Cultured</subject><subject>Connexin 43 - metabolism</subject><subject>Culture Media - chemistry</subject><subject>Edema</subject><subject>Endothelial Cells - cytology</subject><subject>Endothelial Cells - drug effects</subject><subject>Endothelial Cells - metabolism</subject><subject>Endothelial dysfunction</subject><subject>Female</subject><subject>Gene Expression Regulation</subject><subject>Humans</subject><subject>Hypertension</subject><subject>Junctional proteins</subject><subject>MAP Kinase Signaling System - drug effects</subject><subject>Models, Biological</subject><subject>Phosphorylation - drug effects</subject><subject>Pre-Eclampsia - metabolism</subject><subject>Pregnancy</subject><subject>src-Family Kinases - metabolism</subject><subject>TNF-Alpha</subject><subject>Tumor Necrosis Factor-alpha - metabolism</subject><subject>Tumor Necrosis Factor-alpha - pharmacology</subject><subject>Uterine Artery - cytology</subject><subject>Uterine Artery - drug effects</subject><subject>Uterine Artery - metabolism</subject><subject>Vascular Endothelial Growth Factor A - metabolism</subject><subject>Vascular Endothelial Growth Factor A - pharmacology</subject><subject>Zonula Occludens-1 Protein - metabolism</subject><issn>0303-7207</issn><issn>1872-8057</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kc2KFDEUhQtRnHb0AdxIlm66zV91UgiCjNOjMCjI6DakUre60qSSMkk19M538I18FJ_E9PQ46MZVLsm537m5p6qeE7wimKxf7VajgRXFlKwIIWwtH1QLIgVdSlyLh9UCM8yWgmJxVj1JaYcxFjWVj6szxknNmJCL6uc72_cQwWerHTLB5xgcCj2aM0TrAelYigMC34U8gDuqxuCD0weIyPoM22jzAbUHdPNxg7Tv0NfLqw2yCWkzWNhDh_IQw7wd0Di7bCcHaAQzaG_TmFCYIOps_bawku3glhDmfFsXQ2TAOfTr-w_0GRzstTflOqApAhinxylZ_bR61GuX4NndeV592VzeXLxfXn-6-nDx9nppeE3yUoDUjQDRysZwxlrcrIE3mBFsuOl7zbRpJRaSU45pT3tJGsOw6XohmMC8YefVmxN3mtsROlN2FrVTU7SjjgcVtFX_vng7qG3YK8k4bygrgJd3gBi-zZCyGm06_k97CHNStOYlF0np0YucpCaGlCL09zYEq2P2aqdK9uqYvTplX3pe_D3ffcefsIvg9UkAZUt7C1ElY6FstLMRTFZdsP_B_wacvsV7</recordid><startdate>20210820</startdate><enddate>20210820</enddate><creator>Ampey, Amanda C.</creator><creator>Dahn, Rachel L.</creator><creator>Grummer, Mary A.</creator><creator>Bird, Ian M.</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-0396-058X</orcidid><orcidid>https://orcid.org/0000-0003-2444-5816</orcidid></search><sort><creationdate>20210820</creationdate><title>Differential control of uterine artery endothelial monolayer integrity by TNF and VEGF is achieved through multiple mechanisms operating inside and outside the cell – Relevance to preeclampsia</title><author>Ampey, Amanda C. ; Dahn, Rachel L. ; Grummer, Mary A. ; Bird, Ian M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c451t-7e8a97e7b89c433b096e490310c4cffa3acb807842402f2f819c30cdf77370493</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Antigens, CD - metabolism</topic><topic>Cadherins - metabolism</topic><topic>Cell Culture Techniques</topic><topic>Cells, Cultured</topic><topic>Connexin 43 - metabolism</topic><topic>Culture Media - chemistry</topic><topic>Edema</topic><topic>Endothelial Cells - cytology</topic><topic>Endothelial Cells - drug effects</topic><topic>Endothelial Cells - metabolism</topic><topic>Endothelial dysfunction</topic><topic>Female</topic><topic>Gene Expression Regulation</topic><topic>Humans</topic><topic>Hypertension</topic><topic>Junctional proteins</topic><topic>MAP Kinase Signaling System - drug effects</topic><topic>Models, Biological</topic><topic>Phosphorylation - drug effects</topic><topic>Pre-Eclampsia - metabolism</topic><topic>Pregnancy</topic><topic>src-Family Kinases - metabolism</topic><topic>TNF-Alpha</topic><topic>Tumor Necrosis Factor-alpha - metabolism</topic><topic>Tumor Necrosis Factor-alpha - pharmacology</topic><topic>Uterine Artery - cytology</topic><topic>Uterine Artery - drug effects</topic><topic>Uterine Artery - metabolism</topic><topic>Vascular Endothelial Growth Factor A - metabolism</topic><topic>Vascular Endothelial Growth Factor A - pharmacology</topic><topic>Zonula Occludens-1 Protein - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ampey, Amanda C.</creatorcontrib><creatorcontrib>Dahn, Rachel L.</creatorcontrib><creatorcontrib>Grummer, Mary A.</creatorcontrib><creatorcontrib>Bird, Ian M.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Molecular and cellular endocrinology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ampey, Amanda C.</au><au>Dahn, Rachel L.</au><au>Grummer, Mary A.</au><au>Bird, Ian M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Differential control of uterine artery endothelial monolayer integrity by TNF and VEGF is achieved through multiple mechanisms operating inside and outside the cell – Relevance to preeclampsia</atitle><jtitle>Molecular and cellular endocrinology</jtitle><addtitle>Mol Cell Endocrinol</addtitle><date>2021-08-20</date><risdate>2021</risdate><volume>534</volume><spage>111368</spage><epage>111368</epage><pages>111368-111368</pages><artnum>111368</artnum><issn>0303-7207</issn><eissn>1872-8057</eissn><abstract>Uterine artery endothelium undergoes a form of functional adaptation during pregnancy because of an increase in Cx43 communication, resulting in increased Ca2+/IP3 exchange and more synchronous and sustained vasodilator production. We have shown previously that acute exposure to growth factors and TNF can block this adaptation through ERK and/or Src-mediated Cx43 phosphorylation. In preeclampsia such adapted function is already missing, but while elevated TNF is associated with this condition, particularly after 28 weeks (late PE), elevated circulating VEGF165 is not. Given PE is a long term condition emerging in the second half of pregnancy, and is often associated with added edema, we now compare the chronic effects of these two factors on the cell monolayer in order to establish if the breakdown of junctional adherens and tight junctional assemblies in which Cx43 resides could also explain loss of vasodilatory function. We report that while TNF can degrade monolayer integrity even in the 0.1–1 ng/ml physiologic range, VEGF up to 10 ng/ml does not. In addition, the progressive action of TNF is mediated through Src and ERK signaling to promote internalization and destruction of VE-Cadherin (VE-Cad) and ZO-1, as well as the expression and secretion of a variety of proteases. At least one protein degraded from the extracellular space is VE-Cad, resulting in release of a shed VE-Cad protein product, and consistent with monolayer breakdown being sensitive to both Src and MEK/ERK kinase inhibitors and the general protease inhibitor GM6001. We conclude that the greater association of TNF with ‘late’ PE is as much due to its longer term destabilizing effects on junctional assemblies as it is to acute closure of Cx43 channels themselves. New therapies aimed at stabilizing these junctional assemblies may help treat this hypertensive condition.
•TNF but not VEGF damages junctional assemblies at physiologic levels in uterine artery endothelial cells.•TNF acts through multiple mechanisms inside and outside the cell to cause this damage.•Our data supports the argument cytokines are more damaging than growth factors in loss of vasodilation in the preeclampsia.</abstract><cop>Ireland</cop><pub>Elsevier B.V</pub><pmid>34153378</pmid><doi>10.1016/j.mce.2021.111368</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0002-0396-058X</orcidid><orcidid>https://orcid.org/0000-0003-2444-5816</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0303-7207 |
ispartof | Molecular and cellular endocrinology, 2021-08, Vol.534, p.111368-111368, Article 111368 |
issn | 0303-7207 1872-8057 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8344923 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Antigens, CD - metabolism Cadherins - metabolism Cell Culture Techniques Cells, Cultured Connexin 43 - metabolism Culture Media - chemistry Edema Endothelial Cells - cytology Endothelial Cells - drug effects Endothelial Cells - metabolism Endothelial dysfunction Female Gene Expression Regulation Humans Hypertension Junctional proteins MAP Kinase Signaling System - drug effects Models, Biological Phosphorylation - drug effects Pre-Eclampsia - metabolism Pregnancy src-Family Kinases - metabolism TNF-Alpha Tumor Necrosis Factor-alpha - metabolism Tumor Necrosis Factor-alpha - pharmacology Uterine Artery - cytology Uterine Artery - drug effects Uterine Artery - metabolism Vascular Endothelial Growth Factor A - metabolism Vascular Endothelial Growth Factor A - pharmacology Zonula Occludens-1 Protein - metabolism |
title | Differential control of uterine artery endothelial monolayer integrity by TNF and VEGF is achieved through multiple mechanisms operating inside and outside the cell – Relevance to preeclampsia |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T11%3A01%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Differential%20control%20of%20uterine%20artery%20endothelial%20monolayer%20integrity%20by%20TNF%20and%20VEGF%20is%20achieved%20through%20multiple%20mechanisms%20operating%20inside%20and%20outside%20the%20cell%20%E2%80%93%20Relevance%20to%20preeclampsia&rft.jtitle=Molecular%20and%20cellular%20endocrinology&rft.au=Ampey,%20Amanda%20C.&rft.date=2021-08-20&rft.volume=534&rft.spage=111368&rft.epage=111368&rft.pages=111368-111368&rft.artnum=111368&rft.issn=0303-7207&rft.eissn=1872-8057&rft_id=info:doi/10.1016/j.mce.2021.111368&rft_dat=%3Cproquest_pubme%3E2544158229%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2544158229&rft_id=info:pmid/34153378&rft_els_id=S0303720721002124&rfr_iscdi=true |